Trials / Completed
CompletedNCT01722409
A Better Choice for Patients Undergoing Endovascular Coil Embolization
Sevoflurane, Laryngeal Mask Airway and Single-dose Dexmedetomidine: A Better Choice for Patients Undergoing Endovascular Coil Embolization
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- China Medical University, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The investigators designed a double-blind, randomized placebo-controlled study to determine the effects of dexmedetomidine on the recovery characteristics of patients who were scheduled to undergo endovascular coil embolization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sevoflurane and 0.5 μg/kg dexmedetomidine | After induction of general anesthesia, Group DEX1 received a single dexmedetomidine dose of 0.5 μg/kg over 10 minutes. |
| DRUG | sevoflurane and 1 μg/kg dexmedetomidine | After induction of general anesthesia, Group DEX2 received a single dexmedetomidine dose of 1 μg/kg over 10 minutes. |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2012-11-06
- Last updated
- 2015-06-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01722409. Inclusion in this directory is not an endorsement.